• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

高危患者上臂动静脉瘘的通畅率更高。

Superior patency of upper arm arteriovenous fistulae in high risk patients.

机构信息

Department of Surgery, Yale University School of Medicine, New Haven, Connecticut 06520-8089, USA.

出版信息

J Surg Res. 2011 Sep;170(1):157-64. doi: 10.1016/j.jss.2011.03.042. Epub 2011 Apr 16.

DOI:10.1016/j.jss.2011.03.042
PMID:21571318
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3155244/
Abstract

BACKGROUND

Despite an increased propensity to primary failure in forearm arteriovenous fistulae compared with upper arm fistulae, forearm fistulae remain the preferred primary access type for chronic hemodialysis patients. In a high risk patient population with multiple medical comorbidities associated with requirement for intravenous access we compared the rates of access failure in forearm and upper arm fistulae.

MATERIALS AND METHODS

The records of all patients having primary native arteriovenous fistulae placed between 2004 and 2009 at the VA Connecticut Healthcare system were reviewed (n = 118). Primary and secondary patency of upper arm and forearm fistulae were evaluated using Kaplan-Meier survival analysis. The effects of medical comorbidities on access patency were analyzed with Cox regression.

RESULTS

The median time to primary failure of the vascular access was 0.288 y in the forearm group compared with 0.940 y in the upper arm group (P = 0.028). Secondary patency was 52% at 4.9 y in upper arm fistulae compared with 52% at 1.1 y in the forearm group (P = 0.036). There was no significant effect of patient comorbidities on fistula failure; however, there was a trend toward upper arm surgical site as a protective factor for primary fistula patency (hazard ratio = 0.573, P = 0.076).

CONCLUSIONS

In veterans needing hemodialysis, a high risk population with extensive comorbid factors often requiring intravascular access, upper arm fistulae are not only a viable option for primary vascular access, but are likely to be a superior option to classic forearm fistulae.

摘要

背景

尽管与上臂瘘相比,前臂动静脉瘘初次发生失败的倾向更高,但前臂瘘仍然是慢性血液透析患者首选的主要通路类型。在伴有多种与静脉通路需求相关的合并症的高危患者人群中,我们比较了前臂和上臂瘘的通路失败率。

材料和方法

回顾了 2004 年至 2009 年期间在 VA 康涅狄格医疗保健系统中进行的所有初次原发性自体动静脉瘘患者的记录(n = 118)。使用 Kaplan-Meier 生存分析评估上臂和前臂瘘的初次和继发性通畅率。使用 Cox 回归分析评估合并症对通路通畅率的影响。

结果

前臂组血管通路初次失败的中位时间为 0.288 年,而上臂组为 0.940 年(P = 0.028)。上臂瘘的继发性通畅率为 4.9 年时为 52%,而前臂组为 1.1 年时为 52%(P = 0.036)。患者合并症对瘘管失败没有显著影响;然而,上臂手术部位似乎是原发性瘘管通畅的保护因素(风险比=0.573,P = 0.076)。

结论

在需要血液透析的退伍军人中,这是一个高危人群,有广泛的合并症因素,经常需要血管内通路,上臂瘘不仅是主要血管通路的可行选择,而且可能是优于经典前臂瘘的选择。

相似文献

1
Superior patency of upper arm arteriovenous fistulae in high risk patients.高危患者上臂动静脉瘘的通畅率更高。
J Surg Res. 2011 Sep;170(1):157-64. doi: 10.1016/j.jss.2011.03.042. Epub 2011 Apr 16.
2
Clinical effectiveness of open thrombectomy for thrombosed autogenous arteriovenous fistulas and grafts.自体动静脉瘘和移植物血栓形成的开放式血栓切除术的临床效果。
J Vasc Surg. 2018 Jul;68(1):189-196. doi: 10.1016/j.jvs.2017.12.050. Epub 2018 Mar 8.
3
Two-stage brachial-basilic transposition fistula provides superior patency rates for dialysis access in a safety-net population.在一个安全网人群中,二阶段肱-肱动脉转位内瘘为透析通路提供了更高的通畅率。
Surgery. 2010 Oct;148(4):687-93; discussion 693-4. doi: 10.1016/j.surg.2010.07.033. Epub 2010 Aug 19.
4
Comparison of forearm versus upper arm basilic transposition arteriovenous fistulas demonstrates equivalent satisfactory patency.前臂与上臂贵要静脉转位动静脉瘘的比较显示出等效的满意通畅率。
J Vasc Surg. 2019 Oct;70(4):1247-1252. doi: 10.1016/j.jvs.2019.01.093. Epub 2019 May 27.
5
Upper Arm Arteriovenous Grafts are Superior over Forearm Arteriovenous Grafts in Upper Extremity Dialysis Access.在上肢血液透析通路中,上臂动静脉移植物优于前臂动静脉移植物。
Ann Vasc Surg. 2021 Jan;70:131-136. doi: 10.1016/j.avsg.2020.07.009. Epub 2020 Jul 29.
6
Arteriovenous fistulae vs. arteriovenous grafts: a retrospective review of 1,700 consecutive vascular access cases.动静脉内瘘与动静脉移植物:对1700例连续血管通路病例的回顾性研究
J Vasc Access. 2008 Oct-Dec;9(4):231-5.
7
Expected flow parameters within hemodialysis access and selection for remedial intervention of nonmaturing conduits.血液透析通路内的预期血流参数及未成熟血管通路补救干预的选择
Vasc Endovascular Surg. 2008 Apr-May;42(2):150-8. doi: 10.1177/1538574407312648. Epub 2008 Feb 14.
8
Evaluation of the efficacy of the transposed upper arm arteriovenous fistula: a single institutional review of 190 basilic and cephalic vein transposition procedures.转位上臂动静脉内瘘的疗效评估:对190例贵要静脉和头静脉转位手术的单机构回顾
J Vasc Surg. 2007 Jul;46(1):94-99; discussion 100. doi: 10.1016/j.jvs.2007.02.057. Epub 2007 Jun 1.
9
Intermediate-term patency of upper arm arteriovenous fistulae for hemodialysis access in children.儿童用于血液透析通路的上臂动静脉内瘘的中期通畅率
J Pediatr Surg. 2008 Jan;43(1):147-51. doi: 10.1016/j.jpedsurg.2007.09.036.
10
Surgeon experience affects outcome of forearm arteriovenous fistulae more than outcomes of upper-arm fistulae.外科医生的经验对前臂动静脉内瘘结果的影响大于上臂内瘘的结果。
J Vasc Access. 2017 Mar 21;18(2):120-125. doi: 10.5301/jva.5000639. Epub 2017 Jan 3.

引用本文的文献

1
Complications Associated with Permanent Internal Jugular Hemodialysis Catheter: A Retrospective Study.永久性颈内静脉血液透析导管相关并发症:一项回顾性研究
Cureus. 2019 Apr 22;11(4):e4521. doi: 10.7759/cureus.4521.
2
A Systematic Review and Meta-Analysis of Circulating Biomarkers Associated with Failure of Arteriovenous Fistulae for Haemodialysis.与血液透析动静脉内瘘失败相关的循环生物标志物的系统评价和荟萃分析
PLoS One. 2016 Jul 26;11(7):e0159963. doi: 10.1371/journal.pone.0159963. eCollection 2016.
3
Factors associated with complications of vascular access site in hemodialysis patients in Isfahan Aliasghar hospital.伊斯法罕阿里阿斯加尔医院血液透析患者血管通路部位并发症的相关因素。
Iran J Nurs Midwifery Res. 2014 Mar;19(2):208-14.
4
The mouse aortocaval fistula recapitulates human arteriovenous fistula maturation.鼠主动脉-腔静脉瘘管重现了人类动静脉瘘管的成熟过程。
Am J Physiol Heart Circ Physiol. 2013 Dec;305(12):H1718-25. doi: 10.1152/ajpheart.00590.2013. Epub 2013 Oct 4.

本文引用的文献

1
Vascular access use and outcomes: an international perspective from the Dialysis Outcomes and Practice Patterns Study.血管通路的使用情况及结果:来自透析预后与实践模式研究的国际视角
Nephrol Dial Transplant. 2008 Oct;23(10):3219-26. doi: 10.1093/ndt/gfn261. Epub 2008 May 29.
2
Hemodialysis arteriovenous fistula patency revisited: results of a prospective, multicenter initiative.重新审视血液透析动静脉内瘘通畅性:一项前瞻性多中心研究结果
Clin J Am Soc Nephrol. 2008 May;3(3):714-9. doi: 10.2215/CJN.02950707. Epub 2008 Feb 6.
3
Malnutrition after vascular surgery: are patients with chronic renal failure at increased risk?血管手术后的营养不良:慢性肾衰竭患者的风险是否更高?
Am J Surg. 2006 Nov;192(5):e22-7. doi: 10.1016/j.amjsurg.2006.07.004.
4
Risk equation determining unsuccessful cannulation events and failure to maturation in arteriovenous fistulas (REDUCE FTM I).确定动静脉内瘘置管失败事件和成熟失败的风险方程(REDUCE FTM I)。
J Am Soc Nephrol. 2006 Nov;17(11):3204-12. doi: 10.1681/ASN.2006030190. Epub 2006 Sep 20.
5
Safety of carotid endarterectomy in a high-risk population: lessons from the VA and Connecticut.高危人群中行颈动脉内膜切除术的安全性:来自退伍军人事务部和康涅狄格州的经验教训。
J Am Coll Surg. 2006 Sep;203(3):277-82. doi: 10.1016/j.jamcollsurg.2006.05.015. Epub 2006 Jul 3.
6
Clinical practice guidelines for vascular access.血管通路临床实践指南。
Am J Kidney Dis. 2006 Jul;48 Suppl 1:S248-73. doi: 10.1053/j.ajkd.2006.04.040.
7
Hemodialysis clinical practice guidelines for the Canadian Society of Nephrology.加拿大肾脏病学会血液透析临床实践指南
J Am Soc Nephrol. 2006 Mar;17(3 Suppl 1):S1-27. doi: 10.1681/ASN.2005121372.
8
Excerpts from the United States Renal Data System 2004 annual data report: atlas of end-stage renal disease in the United States.美国肾脏数据系统2004年年报摘录:美国终末期肾病图谱
Am J Kidney Dis. 2005 Jan;45(1 Suppl 1):A5-7, S1-280. doi: 10.1053/j.ajkd.2004.10.009.
9
Late creation of vascular access for hemodialysis and increased risk of sepsis.血液透析血管通路建立较晚与败血症风险增加
J Am Soc Nephrol. 2004 Jul;15(7):1936-42. doi: 10.1097/01.asn.0000131524.52012.f8.
10
Vascular access and all-cause mortality: a propensity score analysis.血管通路与全因死亡率:一项倾向评分分析。
J Am Soc Nephrol. 2004 Feb;15(2):477-86. doi: 10.1097/01.asn.0000109668.05157.05.